Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes

Virology(2021)10.1016/j.virol.2021.12.003Source: DataRank Database

Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes is a research paper published in Virology (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.43)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Subbiah Jeeva ORCID,Ki‐Hye Kim,Young‐Man Kwon,Judy Oh,Min Chul Kim ORCID

Live enrichment

PubMed:34929590 PMC:PMC8903020 OpenAlex:https://openalex.org/W4200079410

NIAID DMID

Grant: AI147042

NIAID DMID

Grant: AI154656

National Institute of Allergy and Infectious Diseases

Grant: X-247 rgH3N2

NIAID DMID

Grant: AI093772

NIAID NIH HHS

Grant: R01 AI154656

National Institute of Allergy and Infectious Diseases

Grant: A/Switzerland/9715293/2013

National Institute of Allergy and Infectious Diseases

Grant: FR-1366

NIAID NIH HHS

Grant: R01 AI093772

NIAID NIH HHS

Grant: R21 AI147042

National Institutes of Health

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2022

2024

2026

bronzeLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S0042682221002439/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0042682221002439/pdf

journalhttps://doi.org/10.1016/j.virol.2021.12.003

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34929590

repositoryhttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194489

Fields of Study

Influenza Virus Research StudiesImmune Cell Function and InteractionRespiratory viral infections research

MeSH Terms

Immunogenicity, VaccineAge FactorsAgingAnimalsAntibodies, ViralAntigens, ViralFemaleHumansImmunoglobulin GImmunization, SecondaryInfluenza, HumanInfluenza VaccinesMice, Inbred C57BLModels, MolecularOrthomyxoviridae InfectionsRecombinant Fusion ProteinsVaccinationVaccines, SyntheticViral Matrix ProteinsHemagglutinin Glycoproteins, Influenza VirusMiceInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeCross Protection

Keywords

VirologyBiologyVaccinationHeterologousHemagglutinin (influenza)EpitopeRecombinant DNAVirusAntibodyImmunologyGeneticsGeneCross ProtectionM2eLive Attenuated VirusRecombinant Influenza Virus

Sustainable Development Goals

SDG 0: Good health and well-being